The size of sinusoidal fenestrae is a critical determinant of hepatocyte transduction after adenoviral gene transfer

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Gene Therapy

• Publication date

  2004-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.gt.3302326PMID 15269718
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Enhancement of adenovirus-mediated gene transfer to the airways by DEAE dextran and sodium caprate in vivo.

  2003cited by this paper
• Adenovirus Serotype 5 Fiber Shaft Influences In Vivo Gene Transfer in Mice

  2003cited by this paper
• Age‐related pseudocapillarization of the human liver

  2003cited by this paper
• Hepatic sinusoidal pseudocapillarization with aging in the non-human primate.

  2003cited by this paper
• Receptor Interactions Involved in Adenoviral-Mediated Gene Delivery After Systemic Administration in Non-Human Primates

  2003cited by this paper
• Cellular characterization of the tropism of recombinant adenovirus for the adrenal glands

  2003cited by this paper
• Humoral immune response in mice against a circulating antigen induced by adenoviral transfer is strictly dependent on expression in antigen-presenting cells.

  2003cited by this paper
• Induction of immune tolerance to coagulation factor IX antigen by in vivo hepatic gene transfer.

  2003cited by this paper
• Effect of promoters and enhancers on expression, transgene DNA persistence, and hepatotoxicity after adenoviral gene transfer of human apolipoprotein A-I.

  2002cited by this paper
• Persistent hepatic expression of human apo A-I after transfer with a helper-virus independent adenoviral vector

  2002cited by this paper
• Structural and functional aspects of liver sinusoidal endothelial cell fenestrae: a review

  2002cited by this paper
• Hepatic pseudocapillarisation and atherosclerosis in ageing.

  2002cited by this paper
• Cirrhotic rat livers with extensive fibrosis can be safely transduced with clinical-grade adenoviral vectors. Evidence of cirrhosis reversion

  2002cited by this paper
• Effect of Promoters and Enhancers on Expression, Transgene DNA Persistence, and Hepatotoxicity After Adenoviral Gene Transfer of Human Apolipoprotein A-I

  2002cited by this paper
• CAR- or αv integrin-binding ablated adenovirus vectors, but not fiber-modified vectors containing RGD peptide, do not change the systemic gene transfer properties in mice

  2002cited by this paper
• Sustained phenotypic correction of hemophilia B dogs with a factor IX null mutation by liver-directed gene therapy.

  2002cited by this paper
• The organization of mature Rous sarcoma virus as studied by cryoelectron microscopy.

  2001cited by this paper
• CAR-binding ablation does not change biodistribution and toxicity of adenoviral vectors

  2001cited by this paper
• Organization of Immature Human Immunodeficiency Virus Type 1

  2001cited by this paper
• Sustained expression of human apo A-I following adenoviral gene transfer in mice

  2001cited by this paper
• Liver fibrosis and altered matrix synthesis.

  2001cited by this paper
• Sustained Expression of Human Apolipoprotein A-I after Adenoviral Gene Transfer in C57BL/6 Mice: Role of Apolipoprotein A-I Promoter, Apolipoprotein A-I Introns, and Human Apolipoprotein E Enhancer

  2000cited by this paper
• Adding the Third Dimension to Virus Life Cycles: Three-Dimensional Reconstruction of Icosahedral Viruses from Cryo-Electron Micrographs

  2000cited by this paper
• Modification of the genetic program of human alveolar macrophages by adenovirus vectors in vitro is feasible but inefficient, limited in part by the low level of expression of the coxsackie/adenovirus receptor.

  1999cited by this paper
• Expression of Coxsackie adenovirus receptor and alphav-integrin does not correlate with adenovector targeting in vivo indicating anatomical vector barriers

  1999cited by this paper
• Intravenous administration of recombinant adenoviruses causes thrombocytopenia, anemia and erythroblastosis in rabbits

  1999cited by this paper
• Transgenic rabbits as models for atherosclerosis research.

  1999cited by this paper
• In Vitro and In Vivo Biology of Recombinant Adenovirus Vectors with E1, E1/E2A, or E1/E4 Deleted

  1998cited by this paper
• An interaction between penton base and αv integrins plays a minimal role in adenovirus-mediated gene transfer to hepatocytes in vitro and in vivo

  1998cited by this paper
• Supramolecular organization of immature and mature murine leukemia virus revealed by electron cryo-microscopy: implications for retroviral assembly mechanisms.

  1998cited by this paper
• Effects of adenovirus-mediated human apo A-I gene transfer on neointima formation after endothelial denudation in apo E-deficient mice.

  1997cited by this paper
• Transport of Drugs Across the Xenopus Pulmonary Membrane and Their Absorption Enhancement by Various Absorption Enhancers

  1996cited by this paper
• Liver-Directed Gene Therapy: A Retroviral Vector with a Complete LTR and the ApoE Enhancer-α 1-Antitrypsin Promoter Dramatically Increases Expression of Human α 1-Antitrypsin In Vivo

  1996cited by this paper
• Adenoviral delivery of low-density lipoprotein receptors to hyperlipidemic rabbits: receptor expression modulates high-density lipoproteins.

  1996cited by this paper
• Hepatic Expression of the Catalytic Subunit of the Apolipoprotein B mRNA Editing Enzyme (apobec-1) Ameliorates Hypercholesterolemia in LDL Receptor-Deficient Rabbits

  1996cited by this paper
• Studies on fenestral contraction in rat liver endothelial cells in culture.

  1996cited by this paper
• Liver-directed gene therapy: a retroviral vector with a complete LTR and the ApoE enhancer-alpha 1-antitrypsin promoter dramatically increases expression of human alpha 1-antitrypsin in vivo.

  1996cited by this paper
• In vivo gene therapy for hyperlipidemia: phenotypic correction in Watanabe rabbits by hepatic delivery of the rabbit LDL receptor gene.

  1995cited by this paper
• Depletion of neutrophils and modulation of Kupffer cell function in allyl alcohol-induced hepatotoxicity.

  1995cited by this paper
• Mouse hepatitis virus type 3 infection provokes a decrease in the number of sinusoidal endothelial cell fenestrae both in vivo and in vitro

  1995cited by this paper
• Structure and dynamics of the fenestrae‐associated cytoskeleton of rat liver sinusoidal endothelial cells

  1995cited by this paper
• Lipoproteins and the liver sieve: The role of the fenestrated sinusoidal endothelium in lipoprotein metabolism, atherosclerosis, and cirrhosis

  1995cited by this paper
• Assessment of a method of isolation, purification, and cultivation of rat liver sinusoidal endothelial cells.

  1994cited by this paper
• In vivo correction of low density lipoprotein receptor deficiency in the Watanabe heritable hyperlipidemic rabbit with recombinant adenoviruses.

  1994cited by this paper
• Integrins αvβ3 and αvβ5 promote adenovirus internalization but not virus attachment

  1993cited by this paper
• Apolipoprotein B mRNA editing in 12 different mammalian species: hepatic expression is reflected in low concentrations of apoB-containing plasma lipoproteins.

  1993cited by this paper
• Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment.

  1993cited by this paper
• Localization of a liver-specific enhancer in the apolipoprotein E/C-I/C-II gene locus.

  1993cited by this paper
• Cloning and mRNA tissue distribution of rabbit cholesteryl ester transfer protein.

  1988cited by this paper
• The human alpha 1‐antitrypsin gene is transcribed from two different promoters in macrophages and hepatocytes.

  1987cited by this paper
• Alcoholic liver injury: Defenestration in noncirrhotic livers—a scanning electron microscopic study

  1987cited by this paper
• Small Liver Fenestrae May Explain the Susceptibility of Rabbitsto Atherosclerosis

  1983cited by this paper
• Scanning electron microscope observations on the structure of portal veins, sinusoids and central veins in rat liver.

  1983cited by this paper
• In vivo and in vitro uptake and degradation of acetylated low density lipoprotein by rat liver endothelial, Kupffer, and parenchymal cells.

  1983cited by this paper
• Preparation of isolated rat liver cells.

  1976cited by this paper
• Rabbits as a model for the study of hyperlipoproteinemia and atherosclerosis.

  1975cited by this paper
• An ultrastructural characterization of the endothelial cell in the rat liver sinusoid under normal and various experimental conditions, as a contribution to the distinction between endothelial and Kupffer cells.

  1972cited by this paper
• An electron microscopic study of the fenestrated endothelial lining of rat liver sinusoids.

  1970cited by this paper

• Bio-orthogonal-labeled exosomes reveals specific distribution in vivo and provides potential application in ARDS therapy.

  2025cites this paper
• Dietary alcohol exacerbates the hepatotoxicity induced by pyrrolizidine alkaloids: Hazard from food contamination.

  2021cites this paper
• Methods for Modification of Therapeutic Viruses.

  2020cites this paper
• Challenges in Biomaterial-Based Drug Delivery Approach for the Treatment of Neurodegenerative Diseases: Opportunities for Extracellular Vesicles

  2020cites this paper
• Nano-carriers for drug routeing – towards a new era

  2019cites this paper
• 5 Translational Challenges for Hepatocyte-Directed Gene Transfer

  2018cites this paper
• Adenovirus Vector Toxicity

  2017cites this paper
• Helper-Dependent Adenoviral Vectors for Gene Therapy of Inherited Diseases

  2017cites this paper
• Capsid Engineering of Adenovirus Vectors: Overcoming Early Vector–Host Interactions for Therapy

  2017cites this paper
• Gene Therapy for Inherited Diseases of Liver Metabolism

  2015cites this paper
• Correction of Hyperbilirubinemia in Gunn Rats by Surgical Delivery of Low Doses of Helper-Dependent Adenoviral Vectors

  2014cites this paper
• Extracellular vesicles as drug delivery systems: lessons from the liposome field.

  2014cites this paper
• Challenges and Prospects for Helper-Dependent Adenoviral Vector-Mediated Gene Therapy

  2014cites this paper
• Cationic lipid nanoparticles for therapeutic delivery of siRNA and miRNA to murine liver tumor.

  2013cites this paper
• LCP nanoparticle for tumor and lymph node metastasis imaging

  2013cites this paper
• Pleiotropic effects of HDL: towards new therapeutic areas for HDL-targeted interventions.

  2013cites this paper
• The State of the Art and Future of Gene Medicines

  2013cites this paper
• Helper dependent adenovirus vectors: progress and future prospects.

  2013cites this paper
• Improved Hepatocyte Engraftment After Portal Vein Occlusion in LDL Receptor-Deficient WHHL Rabbits and Lentiviral-Mediated Phenotypic Correction In Vitro.

  2012cites this paper
• Polymer coatings for delivery of nucleic acid therapeutics.

  2012cites this paper
• Liposome based systems for systemic siRNA delivery: stability in blood sets the requirements for optimal carrier design.

  2012cites this paper
• Targeting of Liposomes via PSGL1 for Enhanced Tumor Accumulation

  2012cites this paper
• The Liver as a Target Organ for Gene Therapy: State of the Art, Challenges, and Future Perspectives

  2012cites this paper
• Challenges in the pharmaceutical development of lipid-based short interfering ribonucleic acid therapeutics

  2012cites this paper
• Chapter 9 – Liver and Immune System

  2012cites this paper
• Why the diameter of sinusoidal fenestrae unlikely matters for lipoprotein metabolism and atherosclerosis susceptibility

  2011cites this paper
• Gene therapy for lysosomal storage diseases: progress, challenges and future prospects.

  2011cites this paper
• Helper-Dependent Adenoviral Vectors.

  2011cites this paper
• Helper-dependent adenoviral vectors for liver-directed gene therapy.

  2011cites this paper
• Gene transfer for inborn errors of metabolism of the liver: the clinical perspective.

  2011cites this paper
• Adeno-associated viral vectors for correction of inborn errors of metabolism: progressing towards clinical application.

  2011cites this paper
• Gene transfer for inherited metabolic disorders of the liver: immunological challenges.

  2011cites this paper
• Gene therapy for familial hypercholesterolemia.

  2011cites this paper
• Coagulation factor X mediates adenovirus type 5 liver gene transfer in non-human primates (Microcebus murinus)

  2011cites this paper
• The diameter of liver sinusoidal fenestrae is not a major determinant of lipoprotein levels and atherosclerosis in cholesterol-fed rabbits.

  2011cites this paper
• Advances and Future Challenges in Adenoviral Vector Pharmacology and Targeting

  2011cites this paper
• Genetic Syndromes & Gene Therapy

  2011cites this paper
• Translational Challenges for Hepatocyte-Directed Gene Transfer

  2011cites this paper
• human primates (Microcebus murinus).

  2011cites this paper
• Liver-directed gene therapy with helper-dependent adenoviral vectors: current state of the art and future challenges.

  2011cites this paper
• Retroviral vector-mediated gene therapy for metabolic diseases: an update.

  2011cites this paper
• Vasoactive intestinal peptide increases hepatic transduction and reduces innate immune response following administration of helper-dependent Ad.

  2010cites this paper
• Tropism-Modification Strategies for Targeted Gene Delivery Using Adenoviral Vectors

  2010cites this paper
• The impact of antigen expression in antigen-presenting cells on humoral immune responses against the transgene product

  2010cites this paper
• Gene therapy to improve high-density lipoprotein metabolism and function.

  2010cites this paper
• Transient Increase in Intrahepatic Pressure Mediates Successful Treatment of the Gunn Rat with Reduced Doses of Lentiviral Vector

  2010cites this paper
• The role of liver sinusoidal cells in hepatocyte-directed gene transfer.

  2010cites this paper
• Fixation methods for electron microscopy of human and other liver.

  2010cites this paper
• Hepatocyte-specific ABCA1 transfer increases HDL cholesterol but impairs HDL function and accelerates atherosclerosis.

  2010cites this paper
• PEGylated Adenoviruses: From Mice to Monkeys

  2010cites this paper
• Oligonucleotide Based Liposomal Nanoparticles for Leukemia and Liver Cancer Therapy

  2010cites this paper
• Transductional retargeting of human adenovirus type 5 to ανβ6 integrin for cancer gene therapy

  2009cites this paper
• Progress towards liver and lung-directed gene therapy with helper-dependent adenoviral vectors.

  2009cites this paper
• A new surgical approach to improve gene transfer in liver using lentiviral vectors.

  2009cites this paper
• Three‐dimensional organization of fenestrae labyrinths in liver sinusoidal endothelial cells

  2009cites this paper
• Early effect of a single intravenous injection of ethanol on hepatic sinusoidal endothelial fenestrae in rabbits

  2009cites this paper
• Adenovirus de-targeting from the liver.

  2009cites this paper
• Impacte Metabòlic de l'Activació de la Glicogen Sintasa Hepàtica

  2009cites this paper
• Designing adenoviral vectors for tumor-specific targeting.

  2009cites this paper
• Apolipoprotein A-I and lecithin:cholesterol acyltransferase transfer induce cholesterol unloading in complex atherosclerotic lesions

  2009cites this paper
• Species differences in hepatocyte-directed gene transfer: implications for clinical translation.

  2009cites this paper
• Exosome release by primary B cells.

  2009cites this paper
• Lipid-based systemic delivery of siRNA.

  2009cites this paper
• Cancer gene therapy with targeted adenoviruses

  2008cites this paper
• The size of endothelial fenestrae in human liver sinusoids: implications for hepatocyte-directed gene transfer

  2008cites this paper
• Adenovirus serotype 5 hexon is critical for virus infection of hepatocytes in vivo

  2008cites this paper
• Actin-Binding Drugs: An Elegant Tool to Dissect Subcellular Processes in Endothelial and Cancer Cells

  2008cites this paper
• Progress and prospects: gene therapy for genetic diseases with helper-dependent adenoviral vectors

  2008cites this paper
• Cancer gene therapy with targeted adenoviruses.

  2008cites this paper
• A quantitative assay for measuring clearance of adenovirus vectors by Kupffer cells.

  2008cites this paper
• Polyinosinic acid enhances delivery of adenovirus vectors in vivo by preventing sequestration in liver macrophages.

  2008cites this paper
• Nucleic acid delivery: Where material sciences and bio-sciences meet

  2007cites this paper
• Imaging the modulation of adenoviral kinetics and biodistribution for cancer gene therapy.

  2007cites this paper
• Pseudo-hydrodynamic delivery of helper-dependent adenoviral vectors into non-human primates for liver-directed gene therapy.

  2007cites this paper
• Role and Function of Liver Sinusoidal Endothelial Cells

  2007cites this paper
• Contribution of high‐resolution correlative imaging techniques in the study of the liver sieve in three‐dimensions

  2007cites this paper
• Kupffer cells are obligatory for Plasmodium yoelii sporozoite infection of the liver

  2007cites this paper
• Imaging the Modulation of Adenoviral Kinetics and Biodistribution for Cancer Gene Therapy.

  2007cites this paper
• Fiber Shaft-Chimeric Adenovirus Vectors Lacking the KKTK Motif Efficiently Infect Liver Cells In Vivo

  2007cites this paper
• Species differences in transgene DNA uptake in hepatocytes after adenoviral transfer correlate with the size of endothelial fenestrae

  2007cites this paper
• Striking out at disseminated metastases: the systemic delivery of oncolytic viruses.

  2006cites this paper
• Circulating, soluble forms of major histocompatability complex antigens are not exosome‐associated

  2006cites this paper
• Modified Adenoviral Vectors Ablated for Coxsackievirus–Adenovirus Receptor, αv Integrin, and Heparan Sulfate Binding Reduce In Vivo Tissue Transduction and Toxicity

  2006cites this paper
• Lipid emulsions potently increase transgene expression in hepatocytes after adenoviral transfer.

  2006cites this paper
• Chapter 9 – The Liver and the Immune System

  2006cites this paper
• Elimination of Innate Immune Responses and Liver Inflammation by PEGylation of Adenoviral Vectors and Methylprednisolone

  2005cites this paper
• Gene therapy for inborn errors of liver metabolism.

  2005cites this paper
• Increased hepatic transduction with reduced systemic dissemination and proinflammatory cytokines following hydrodynamic injection of helper-dependent adenoviral vectors.

  2005cites this paper
• Local delivery of a viral vector mitigates neutralization by antiviral antibodies and results in efficient transduction of rabbit liver.

  2005cites this paper
• Helper-Dependent Adenoviral Vectors for Gene Therapy

  2005cites this paper
• How molecular microscopy revealed new insights into the dynamics of hepatic endothelial fenestrae in the past decade

  2004cites this paper
• Targeted Adenovirus Vectors

  2004cites this paper